SMERNICE ZA ODKRIVANJE IN ZDRAVLJENJE PERIFERNE ARTERIJSKE BOLEZNI

  • Aleš Blinc Klinični oddelek za žilne bolezni Klinični center Zaloška 7 1525 Ljubljana
  • Miloš Šurlan Klinični inštitut za radiologijo Klinični center Zaloška 7 1525 Ljubljana
  • Tomaž Ključevšek Klinični inštitut za radiologijo Klinični center Zaloška 7 1525 Ljubljana
  • Tomislav Klokočovnik Klinični oddelek za kardiovaskularno kirurgijo Klinični center Zaloška 7 1525 Ljubljana
  • Vojko Kanič Oddelek za kardiologijo in angiologijo Splošna in učna bolnišnica Maribor Ljubljanska 5 Maribor
  • Anton Lobnik Oddelek za kardiologijo in angiologijo Splošna in učna bolnišnica Maribor Ljubljanska 5 Maribor
  • Matija Kozak Klinični oddelek za žilne bolezni Klinični center Zaloška 7 1525 Ljubljana
  • Mišo Šabovič Klinični oddelek za žilne bolezni Klinični center Zaloška 7 1525 Ljubljana
  • Pavel Poredoš Klinični oddelek za žilne bolezni Klinični center Zaloška 7 1525 Ljubljana

Abstract

*

Downloads

Download data is not yet available.

References

The TASC working group. Management of peripheral arterial disease – Transatlantic inter-society consensus. Acute limb ischemia. Int Angiol 2000; 19: Suppl 1: 143–79.

Ouriel K, Veith FJ, Sasahara AA. A comparison of recombinant urokinase with vascular surgery as initial treatment of acute arterial occlusion of the legs. Thrombolysis or Peripheral Arterial Surgery (TOPAS) investigators. N Engl J Med 1998; 338: 1105–11.

Davies B, Braithwaite BD, Birch PA, Porskitt KR, Heather BP, Earnshaw JJ. Acute leg ischemia in Gloucestershire. Br J Surg 1997; 84: 504–8.

Costantini V, Lenti M. Treatment of acute occlusion of peripheral arteries. Thromb Res 2002; 106: V285–94.

Pentti J, Salenius JP, Kuukasjarvi P, Tarkka M. Outcome of surgical treatment in accute upper limb ischaemia. Ann Chir Gynaecol 1995; 84: 25–8.

Pemberton M, Varty K, Nydahl S, Bell PR. The surgical management of acute limb ischaemia due to native vessel occlusion. Eur J Vasc Endovasc Surg 1999; 17: 72–6.

Working Party on Thrombolysis in the Management of Limb Ischemia. Thrombolysis in the management of lower limb peripheral arterial occlusion – a consensus document. J Vasc Interv Radiol 2003; 7: S337–49.

The TASC working group. Management of peripheral arterial disease – Transatlantic inter-society consensus. Intermittent claudication. Int Angiol 2000; 19: Suppl 1: 57–139.

Fontaine R, Kim M, Kieny R. Die chirurgische Behandlung der peripheren Durchblutungsstörungen. Helv Chir Acta 1954; 5/6: 499–533.

Rutheford RB, Baker JD, Ernst C, Johnston KW, Porter JM, Ahn S, Jones DN. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg 1997; 26: 517–38.

The TASC working group. Management of peripheral arterial disease – Transatlantic inter-society consensus. Introduction. Int Angiol 2000; 19: Suppl 1: 1–52.

The TASC working group. Management of peripheral arterial disease – Transatlantic inter-society consensus. Critical limb ischemia. Int Angiol 2000; 19, Suppl 1: 183–304.

Dormandy JA, Stock G eds. Critical leg ischemia – its patophysiology and management. Berlin: Springer Verlag; 1990.

Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, Olin JW, Krook SH, Hunninghake DB, Comerota AJ, Walsh ME, McDermott MM; Hiatt WR. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001; 286: 1317–24.

Sarnak MJ, Levey AS. Cardiovascular disease and chronic renal disease: a new paradigm. Am J Kidney Dis 2000; 35: Suppl 1: S117–31.

O’Hare A, Johansen K. Lower-extremity peripheral arterial disease among patients with end-stage renal disease. J Am Soc Nephrol 2001; 12: 2838–47.

Hiatt WR. Medical treatment of peripheral arterial disease and claudication. N Engl J Med 2001; 344: 1608–21.

Third Joint Task Force of European and other Societies on Cardiovascular Disease in Clinical Practice. Executive summary – European Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 2003; 24: 1601–10.

Guidelines Committee. 2003, European Society of Hypertension – European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21: 1011–53.

Antithrombotic Trialists’ Collaboration. Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002; 324: 71–86.

Goldhaber SZ, Manson JE, Stampfer MJ, LaMotte F, Rosner B, Buring JE, Hennekens CH. Low-dose aspirin and subsequent peripheral arterial surgery in the Physicians’ Health Study. Lancet 1992; 340: 143–5.

Pedersen TR, Kjekshus J, Pyorala K, Olsson AG, Cook TJ, Musliner TA, Tobert JA, Haghfelt T. Effect of simvastatin on ischemic signs and symptoms in the Scandinavian Simvastatin Survival Study (4S). Am J Cardiol 1998; 81: 333–5.

The Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000; 342: 145–53.

Dahlöf B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, Faire U, Fyhrquist F, Ibsen H, Kristiansson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002; 359: 995–1003.

Stewart KJ, Hiatt WR, Regensteiner JG, Hirsch AT. Exercise training for claudication. N Engl J Med 2002; 347: 1941–51.

How to Cite
1.
Blinc A, Šurlan M, Ključevšek T, Klokočovnik T, Kanič V, Lobnik A, Kozak M, Šabovič M, Poredoš P. SMERNICE ZA ODKRIVANJE IN ZDRAVLJENJE PERIFERNE ARTERIJSKE BOLEZNI. TEST ZdravVestn [Internet]. 1 [cited 5Aug.2024];73(9). Available from: http://vestnik-dev.szd.si/index.php/ZdravVest/article/view/2354
Issue
Vol 73 No 9 (2004): September
Section
Quality and safety


The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.

The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory

The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.

The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.

The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.